• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖原贮积病Ib型中的高钙血症及并发的TBX1突变:病例报告

Hypercalcemia and co-occurring TBX1 mutation in Glycogen Storage Disease Type Ib: case report.

作者信息

Kasmi Zakaria, Ain El Hayat Imane, Aadam Zahra, Errami Abderrahmane, Benhsaien Ibtihal, El Bakkouri Jalila, Ben Sabbahia Dalal, Atrassi Meryem, Bousfiha Ahmed Aziz, Ailal Fatima

机构信息

Laboratory of Clinical Immunology, Inflammation, and Allergy (LICIA), Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.

Department of Pediatrics I, Unit of Clinical Immunology and Infectious Diseases, Abderrahim El Harouchi Mother-Children Hospital, Ibn Rochd University Hospital, Casablanca, Morocco.

出版信息

BMC Med Genomics. 2025 Jan 7;18(1):5. doi: 10.1186/s12920-024-02057-5.

DOI:10.1186/s12920-024-02057-5
PMID:39773724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11708236/
Abstract

Glycogen Storage Disease Type Ib (GSD-Ib) is a rare autosomal recessive metabolic disorder caused by mutations in SLC37A4, leading to a deficiency in glucose-6-phosphate translocase. This disorder is characterized by impaired glycogenolysis and gluconeogenesis, resulting in clinical and metabolic manifestations. We report a three-month-old Moroccan female patient presenting with doll-like facies, hepatomegaly, dysmorphic features, and developmental delays. Laboratory analysis revealed hypoglycemia, elevated triglyceride levels, hypercalcemia, and neutropenia. Genetic testing confirmed a homozygous pathogenic variant in SLC37A4 and a heterozygous variant of uncertain significance in TBX1. Initial management included a lactose-free and galactose-free diet, multivitamin supplementation, and granulocyte colony-stimulating factor (G-CSF) therapy to address neutropenia. A novel aspect of this case involves hypercalcemia as an unusual finding in GSD-Ib and the co-occurrence of a variant in the TBX1 gene, which is not typically associated with the disease but may contribute to the patient's clinical presentation. These findings add a new dimension to our understanding of GSD-Ib and suggest potential avenues for future research to elucidate these genetic interactions and their impact on clinical outcomes.

摘要

1b型糖原贮积病(GSD-Ib)是一种罕见的常染色体隐性代谢紊乱疾病,由SLC37A4基因突变引起,导致葡萄糖-6-磷酸转运酶缺乏。这种疾病的特征是糖原分解和糖异生受损,从而产生临床和代谢表现。我们报告了一名三个月大的摩洛哥女性患者,她表现出娃娃脸、肝肿大、畸形特征和发育迟缓。实验室分析显示低血糖、甘油三酯水平升高、高钙血症和中性粒细胞减少。基因检测证实SLC37A4存在纯合致病性变异,TBX1存在意义不确定的杂合变异。初始治疗包括无乳糖和无半乳糖饮食、多种维生素补充以及粒细胞集落刺激因子(G-CSF)治疗以解决中性粒细胞减少问题。该病例的一个新情况是高钙血症作为GSD-Ib中不寻常的发现,以及TBX1基因变异的同时出现,该基因通常与该疾病无关,但可能导致患者的临床表现。这些发现为我们对GSD-Ib的理解增添了新的维度,并为未来研究阐明这些基因相互作用及其对临床结果的影响提供了潜在途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e7f/11708236/098e5bff3357/12920_2024_2057_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e7f/11708236/48ae59674b17/12920_2024_2057_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e7f/11708236/098e5bff3357/12920_2024_2057_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e7f/11708236/48ae59674b17/12920_2024_2057_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e7f/11708236/098e5bff3357/12920_2024_2057_Fig2_HTML.jpg

相似文献

1
Hypercalcemia and co-occurring TBX1 mutation in Glycogen Storage Disease Type Ib: case report.糖原贮积病Ib型中的高钙血症及并发的TBX1突变:病例报告
BMC Med Genomics. 2025 Jan 7;18(1):5. doi: 10.1186/s12920-024-02057-5.
2
A novel SLC37A4 missense mutation in GSD-Ib without hepatomegaly causes enhanced leukocytes endoplasmic reticulum stress and apoptosis.一种新型 SLC37A4 错义突变导致 GSD-Ib 无肝肿大,但增强了白细胞内质网应激和凋亡。
Mol Genet Genomic Med. 2021 Jan;9(1):e1568. doi: 10.1002/mgg3.1568. Epub 2020 Dec 5.
3
Glycogen storage disease type 1b: an early onset severe phenotype associated with a novel mutation (IVS4) in the glucose 6-phosphate translocase (SLC37A4) gene in a Turkish patient.1b型糖原贮积病:一名土耳其患者中与葡萄糖6-磷酸转运体(SLC37A4)基因新突变(IVS4)相关的早发严重表型。
Genet Couns. 2014;25(4):389-94.
4
CRISPR/Cas9 genome editing of SLC37A4 gene elucidates the role of molecular markers of endoplasmic reticulum stress and apoptosis in renal involvement in glycogen storage disease type Ib.CRISPR/Cas9 基因编辑 SLC37A4 基因阐明了内质网应激和细胞凋亡的分子标志物在糖原贮积病 Ib 型肾受累中的作用。
Gene. 2019 Jun 30;703:17-25. doi: 10.1016/j.gene.2019.04.002. Epub 2019 Apr 3.
5
Impact of genotype on neutropenia in a large cohort of Serbian patients with glycogen storage disease type Ib.基因型对一大群塞尔维亚糖原贮积病Ib型患者中性粒细胞减少症的影响。
Eur J Med Genet. 2020 Mar;63(3):103767. doi: 10.1016/j.ejmg.2019.103767. Epub 2019 Sep 16.
6
Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants.对塞尔维亚人群中 GSD I 的遗传特征进行分析,结果出人意料地发现 GSD Ib 发病率较高,以及 3 种新型 SLC37A4 变异体。
Clin Genet. 2018 Feb;93(2):350-355. doi: 10.1111/cge.13093. Epub 2017 Dec 11.
7
Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib.3 例糖原贮积病 Ib 型的临床分析及长期治疗监测
BMC Med Genomics. 2021 Mar 17;14(1):81. doi: 10.1186/s12920-021-00936-9.
8
Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report.糖原贮积病Ib型合并中性粒细胞减少、马蹄肾和动静脉畸形患者的SLC37A4基因新突变:病例报告
Immunol Res. 2023 Feb;71(1):107-111. doi: 10.1007/s12026-022-09320-w. Epub 2022 Sep 21.
9
[Mutation in the SLC37A4 gene of glycogen storage disease type Ib in 15 families of the mainland of China].[中国大陆15个家庭中I型糖原贮积病的SLC37A4基因突变]
Zhonghua Er Ke Za Zhi. 2011 Mar;49(3):203-8.
10
Glycogen storage disease type Ib: the first case in Taiwan.第一型糖原贮积症:台湾首例病例。
Pediatr Neonatol. 2009 Jun;50(3):125-8. doi: 10.1016/S1875-9572(09)60048-6.

本文引用的文献

1
Case report: The success of empagliflozin therapy for glycogen storage disease type 1b.病例报告:恩格列净治疗 1b 型糖原贮积症的成功。
Front Endocrinol (Lausanne). 2024 Jun 11;15:1365700. doi: 10.3389/fendo.2024.1365700. eCollection 2024.
2
Clinical Remission of Severe Crohn's Disease with Empagliflozin Monotherapy in a Pediatric Patient with Glycogen Storage Disease Type 1b.恩格列净单药治疗1b型糖原贮积病患儿重度克罗恩病实现临床缓解
JPGN Rep. 2023 Aug 28;4(4):e356. doi: 10.1097/PG9.0000000000000356. eCollection 2023 Nov.
3
Glycogen Storage Disease Type I With Hypercalcemia in an Infant: A Case Report.
婴儿I型糖原贮积病伴高钙血症:一例报告
Cureus. 2023 Oct 13;15(10):e46987. doi: 10.7759/cureus.46987. eCollection 2023 Oct.
4
Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients.恩格列净治疗两名1b型小儿糖原贮积病患者取得良好疗效。
Front Pediatr. 2022 Nov 23;10:1071464. doi: 10.3389/fped.2022.1071464. eCollection 2022.
5
Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report.糖原贮积病Ib型合并中性粒细胞减少、马蹄肾和动静脉畸形患者的SLC37A4基因新突变:病例报告
Immunol Res. 2023 Feb;71(1):107-111. doi: 10.1007/s12026-022-09320-w. Epub 2022 Sep 21.
6
Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre.了解 SGLT2 抑制剂在 Ib 型糖原贮积症中的作用:英国一个中心的经验。
Orphanet J Rare Dis. 2022 May 12;17(1):195. doi: 10.1186/s13023-022-02345-2.
7
Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib.糖原贮积病 Ib 型中性粒细胞分化异常的分子机制。
Cell Mol Life Sci. 2022 Apr 18;79(5):246. doi: 10.1007/s00018-022-04267-5.
8
Vitamin D-dependent Hypercalcemia.维生素 D 依赖性高钙血症。
Endocrinol Metab Clin North Am. 2021 Dec;50(4):729-742. doi: 10.1016/j.ecl.2021.08.005.
9
Adipose TBX1 regulates β-adrenergic sensitivity in subcutaneous adipose tissue and thermogenic capacity in vivo.脂肪组织中的TBX1调节皮下脂肪组织中的β-肾上腺素能敏感性和体内产热能力。
Mol Metab. 2020 Jun;36:100965. doi: 10.1016/j.molmet.2020.02.008. Epub 2020 Feb 18.
10
The Genetics and Epigenetics of 22q11.2 Deletion Syndrome.22q11.2缺失综合征的遗传学与表观遗传学
Front Genet. 2020 Feb 6;10:1365. doi: 10.3389/fgene.2019.01365. eCollection 2019.